Skip to main content

Strange: Bullish BIO Analysts Actually See -12.97% Downside

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Bio-Rad Laboratories Inc (BIO). The average 12-month price target for BIO — averaging the work of 4 analysts — reveals an average price target of $560.00/share..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.